Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139672
Status:
COMPLETED
Last Update Posted:
2008-06-17
First Post:
2005-08-29
Brief Title:
A Study To Investigate The Effect Of PD-217014 On Abdominal PainDiscomfort In Patients With IBS
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multi-Center Double-Blind Randomized Placebo-Controlled Parallel Group Study To Investigate The Effect Of Pd-217014 In Patients With Irritable Bowel Syndrome IBS
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effectiveness of PD-217014 in the treatment of abdominal paindiscomfort associated with irritable bowel disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None